KL-6 was initially associated with non-Small Cell Lung Cancer, and a high initial KL-6 level in serum or plasma may predict poor clinical outcome, including 5-year survival in these patients [13,14,15,16]. This evidence concerns the gene MUC1 and non-small cell lung carcinoma.